Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by Daredevil1964on Sep 16, 2020 11:34am
279 Views
Post# 31567102

7 Cannabis Stocks That Cantor Fitzgerald Recommends

7 Cannabis Stocks That Cantor Fitzgerald Recommendshttps://finance.yahoo.com/news/7-cannabis-stocks-cantor-fitzgerald-193159230.html
https://finance.yahoo.com/news/7-cannabis-stocks-cantor-fitzgerald-193159230.html

Aphria (APHA)

Canadian cannabis producer Aphria disappointed investors with its fourth-quarter earnings report. Revenue was up 18% from a year ago but just 5% from the third quarter. Like many other cannabis stocks, Aphria also recorded a nearly $50 million impairment charge during the quarter. Zuanic says the headline numbers may not have been particularly impressive, but Aphria's 27% sequential recreational cannabis sales growth tripled the average growth rate of its Canadian peers. Earnings before interest, taxes, depreciation and amortization, or EBITDA, margins also surpassed competitors, Zuanic says. Cantor Fitzgerald has an "overweight" rating and $9.48 price target for APHA stock.

<< Previous
Bullboard Posts
Next >>